These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 32181526

  • 1. CPNE1 predicts poor prognosis and promotes tumorigenesis and radioresistance via the AKT singling pathway in triple-negative breast cancer.
    Shao Z, Ma X, Zhang Y, Sun Y, Lv W, He K, Xia R, Wang P, Gao X.
    Mol Carcinog; 2020 May; 59(5):533-544. PubMed ID: 32181526
    [Abstract] [Full Text] [Related]

  • 2. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
    Li M, Li AQ, Zhou SL, Lv H, Wei P, Yang WT.
    J Exp Clin Cancer Res; 2020 May 24; 39(1):92. PubMed ID: 32448269
    [Abstract] [Full Text] [Related]

  • 3. CPNE1 mediates glycolysis and metastasis of breast cancer through activation of PI3K/AKT/HIF-1α signaling.
    Cao J, Cao R, Liu Y, Dai T.
    Pathol Res Pract; 2023 Aug 24; 248():154634. PubMed ID: 37454492
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of POU3F2 promotes radioresistance in triple-negative breast cancer via Akt pathway activation.
    Zhang H, Zheng J, Fu Y, Ling J, Liu Z, Lin X, Dong X, Sun Y, Tan T, Guo Z, Xie G.
    Breast Cancer Res Treat; 2023 Apr 24; 198(3):437-446. PubMed ID: 36797433
    [Abstract] [Full Text] [Related]

  • 5. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
    Zheng X, Huang M, Xing L, Yang R, Wang X, Jiang R, Zhang L, Chen J.
    Mol Cancer; 2020 Apr 07; 19(1):73. PubMed ID: 32264877
    [Abstract] [Full Text] [Related]

  • 6. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
    Cheng G, Fan X, Hao M, Wang J, Zhou X, Sun X.
    Mol Cancer; 2016 Apr 30; 15(1):30. PubMed ID: 27130446
    [Abstract] [Full Text] [Related]

  • 7. Knockdown of Kinase Family 15 Inhibits Cancer Cell Proliferation In vitro and its Clinical Relevance in Triple-Negative Breast Cancer.
    Sheng J, Xue X, Jiang K.
    Curr Mol Med; 2019 Apr 30; 19(2):147-155. PubMed ID: 30854965
    [Abstract] [Full Text] [Related]

  • 8. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H, Wu T, Xie D, Li D, Hua K, Hu J, Fang L.
    Cell Physiol Biochem; 2018 Apr 30; 48(5):1968-1982. PubMed ID: 30092563
    [Abstract] [Full Text] [Related]

  • 9. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T, Liu M, Luo H, Wu C, Tang X, Tang S, Hu P, Yan Y, Wang Z, Tu G.
    J Steroid Biochem Mol Biol; 2014 Sep 30; 143():392-403. PubMed ID: 24874276
    [Abstract] [Full Text] [Related]

  • 10. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.
    Chen H, Pan H, Qian Y, Zhou W, Liu X.
    Mol Cancer; 2018 Jan 08; 17(1):4. PubMed ID: 29310680
    [Abstract] [Full Text] [Related]

  • 11. Micropeptide CIP2A-BP encoded by LINC00665 inhibits triple-negative breast cancer progression.
    Guo B, Wu S, Zhu X, Zhang L, Deng J, Li F, Wang Y, Zhang S, Wu R, Lu J, Zhou Y.
    EMBO J; 2020 Jan 02; 39(1):e102190. PubMed ID: 31755573
    [Abstract] [Full Text] [Related]

  • 12. lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling.
    Zheng S, Li M, Miao K, Xu H.
    J Cell Biochem; 2020 Mar 02; 121(3):2225-2235. PubMed ID: 31692053
    [Abstract] [Full Text] [Related]

  • 13. JARID2 activation by NFYA promotes stemness of triple-negative breast cancer cells through the PI3K/AKT pathway.
    Li J, Zhang X, Liu X, Ma X, Wang Y, Liu Y.
    Expert Rev Anticancer Ther; 2024 Oct 02; 24(10):1029-1040. PubMed ID: 39254227
    [Abstract] [Full Text] [Related]

  • 14. RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer.
    Weng TH, Yao MY, Xu XM, Hu CY, Yao SH, Liu YZ, Wu ZG, Tang TM, Fu PF, Wang MH, Yao HP.
    Cancer Res Treat; 2020 Jul 02; 52(3):973-986. PubMed ID: 32324988
    [Abstract] [Full Text] [Related]

  • 15. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
    Weng YS, Tseng HY, Chen YA, Shen PC, Al Haq AT, Chen LM, Tung YC, Hsu HL.
    Mol Cancer; 2019 Mar 18; 18(1):42. PubMed ID: 30885232
    [Abstract] [Full Text] [Related]

  • 16. Rhophilin-associated tail protein 1 promotes migration and metastasis in triple negative breast cancer via activation of RhoA.
    Liu Q, Huang X, Li Q, He L, Li S, Chen X, Ouyang Y, Wang X, Lin C.
    FASEB J; 2020 Aug 18; 34(8):9959-9971. PubMed ID: 32427399
    [Abstract] [Full Text] [Related]

  • 17. PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer.
    Yu TJ, Liu YY, Li XG, Lian B, Lu XX, Jin X, Shao ZM, Hu X, Di GH, Jiang YZ.
    Cancer Res; 2021 Nov 01; 81(21):5491-5505. PubMed ID: 34408002
    [Abstract] [Full Text] [Related]

  • 18. Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer.
    Bhardwaj A, Singh H, Rajapakshe K, Tachibana K, Ganesan N, Pan Y, Gunaratne PH, Coarfa C, Bedrosian I.
    Oncotarget; 2017 Mar 21; 8(12):19645-19660. PubMed ID: 28160548
    [Abstract] [Full Text] [Related]

  • 19. MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer.
    Xu X, Zhang Y, Jasper J, Lykken E, Alexander PB, Markowitz GJ, McDonnell DP, Li QJ, Wang XF.
    Oncotarget; 2016 Apr 12; 7(15):20381-94. PubMed ID: 26967387
    [Abstract] [Full Text] [Related]

  • 20. Knockdown of miR-182 promotes apoptosis via regulating RIP1 deubiquitination in TNF-α-treated triple-negative breast cancer cells.
    Wo L, Lu D, Gu X.
    Tumour Biol; 2016 Oct 12; 37(10):13733-13742. PubMed ID: 27476169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.